期刊文献+

Akt shRNA载体的构建及其对结肠癌细胞株Lovo Akt基因表达的抑制作用 被引量:5

Construction of the expression vector for short-hairpin RNA-mediated Akt gene silencing in Lovo cells
下载PDF
导出
摘要 目的构建靶向人Akt基因的shRNA真核表达载体,通过RNAi下调Akt基因在结肠癌Lovo细胞系中的表达,观察对结肠癌细胞生长的影响。方法将靶向人Akt基因的两条shRNA(Akt1-U6-1#;Akt1-U6-2#)表达序列克隆到入门载体pENTRTM/U6的黏性末端,测序鉴定后与目的表达载体Plentio/Block-iT DEST Vector进行LR位点特异性重组;分别将入门载体与目的表达载体转染入Lovo细胞,对细胞株行RT-PCR和Western blotting检测,观察siRNA对靶基因Akt的抑制效果。结果 DNA测序证实pENTRTM/U6-TF-shRNA入门载体和Plentio/Block-iT DEST目的表达载体为阳性克隆,转染Lovo细胞后,Akt基因在mRNA和蛋白水平的表达量受到明显抑制。结论成功构建了靶向人Akt的shRNA表达载体,且该载体在体外能有效抑制Lovo细胞Akt基因表达,为进一步研究Akt的功能和肿瘤的基因治疗奠定了实验基础。 Objective To construct a eukaryotic expression vector of short-hairpin RNA(shRNA) targeting human Akt gene and assess the effect of Akt gene silencing on the growth of colon cancer Lovo cells.Methods Two shRNAs targeting human Akt gene were cloned into pENTRTM/U6 plasmid to obtain the entry clones,and the positive clones were verified by sequencing.After recombination of the pENTRTM/U6 entry constructs and Plenti6/Block-iT DEST vector,the positive clones were confirmed by sequencing.Lovo cells were transfected by the entry vector and DEST Vector,and RT-PCR and Western blotting were performed to detect the interference of Akt gene expressions.Results The pENTRTM/U6 entry clones carrying Akt shRNA and pLenti6/DEST-pENTRTM/U6-Akt shRNA were successfully constructed.Both of the vectors were transfected into Lovo cells and resulted in obvious knockdown of the mRNA and protein expressions of Akt.Conclusion The Akt siRNA expression vector constructed can significantly inhibit Akt gene expression in Lovo cells,which facilitates further studies of Akt function and tumor gene therapy.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第11期1914-1917,共4页 Journal of Southern Medical University
基金 广东省自然科学基金(10151040701000031 S2011010004750)
关键词 蛋白激酶B SHRNA 表达载体 结肠癌细胞 Akt short-hairpin RNA expression vector Lovo cells
  • 相关文献

参考文献9

  • 1Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream[J]. Cell, 2007, 129(7): 1261-74.
  • 2Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells[J], Nat Biotechnol, 2002, 20(5): 497-500.
  • 3Reynolds A, Devin L, Boese Q, et al. Rational siRNA design for RNA interference[J]. Nat Biotechnol, 2004, 22(3): 326-30.
  • 4Yang B, Zador Z, Verkman AS. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling[J]. J Biol Chem, 2008, 283(22): 15280-6.
  • 5Izquierdo M. Short interfering RNAs as a tool for Cancer gene theralay[J]. Cancer Gene Ther, 2005, 12(3): 217-27.
  • 6Malik I, Garrido M, Bahr M, et al. Comparison of test systems for RNAinterference [J]. Biochem Biophys Res Commun, 2006, 341 (1): 245-53.
  • 7Abbott RT, Tripp S, Perkins SL, et al. Analysis of the PI-3- Kinase-PTEN-AKT pathway in human lymphoma and leukemia ,,usino ;i ee.ll linee microarrav[J]. Mod Pathol, 2003, 16(6): 607-12.
  • 8Khor TO, Gul YA, lthnin H, et al. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma[J]. Cancer Lett, 2004, 210(2): 139-50.
  • 9黄宪章,王前,郑磊,陈晓,熊石龙,包杰,丁海明,黄妩姣,庄俊华.人CDK2基因RNAi慢病毒载体的构建与鉴定[J].中国病理生理杂志,2008,24(6):1246-1248. 被引量:2

二级参考文献11

  • 1郭海霞,李文益,徐令,苏浩彬,黎阳,夏焱,梁立阳.慢病毒载体携带的VEGFR_2 shRNA对HL60的体外杀伤作用[J].中国病理生理杂志,2007,23(6):1053-1057. 被引量:6
  • 2张斌,单志新,林秋雄,周志凌,邓春玉,郭爱林,符永恒,谭虹虹,余细勇.人微小RNA-133a(miR-133a)重组腺病毒的构建和鉴定[J].中国病理生理杂志,2007,23(7):1402-1407. 被引量:3
  • 3Scatizzi JC, Hutcheson J, Bickel E, et al. p21Cipl is required for the development of monocytes and their response to serum transfer - induced arthritis [ J ]. Am J Pathol, 2006, 168(5) :1531 - 1541.
  • 4Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus - delivered stable gene silencing by RNAi in primary cells [J]. RNA, 2003, 9(4):493-501.
  • 5Tsai LH, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A and p33 -kinase[ J ]. Nature, 1991, 353(6340) : 174 - 177.
  • 6Giordano A, Bellacchio E, Bagella L, et al. Interaction between the Cdk2/cyclin A complex and a small molecule derived from the pRb2/p130 spacer domain: a theoretical model[ J]. Cell Cycle,2007,6( 21 ) :2591 - 2593.
  • 7Hampton T. Arthritis gene therapy trial resumes[ J ]. JAMA, 2008, 299( 1 ) :28.
  • 8Manis JP. Knock out, knock in, knock down - genetically manipulated mice and the Nobel Prize[ J]. N Engl J Med, 2007,357 (24) :2426 - 2429.
  • 9Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [ J ]. Science, 2002, 296 ( 5567 ) :550 - 553.
  • 10Howard KA, Kjems J. Polycation - based nanoparticle delivery for improved RNA interference therapeutics[ J ]. Expert Opin Biol Ther, 2007, 7(12) :1811 - 1822.

共引文献1

同被引文献52

  • 1杨清,张淑兰,王玉.子宫内膜癌组织中p-PKB及仅含BH3域蛋白的表达及其相关性[J].中国肿瘤临床,2006,33(16):912-915. 被引量:5
  • 2Rohan T E,Li S Q,Hartwick R,Kandel R A.p53 alterations andprotein accmulation in benign breast tissue and breast cancer risk:acohort study[J].Cancer Epidemiol Biomarkers Prev,2006,15:1316-1323.
  • 3Li-Ning-T E,Ronchetti R,Torres-Cabala C,Merino M J.Roleof chromogenic in situ hybridization(CISH)in the evaluation ofHER2 status in breast carcinoma:comparison with immunohisto-chemistry and FISH[J].Int J Surg Pathol,2005,13:343-351.
  • 4Cheng J Q,Godwin A K,Bellacosa A,Taguchi T,Franke T F,Ham-ilton T C.AKT2,a putative oncogene encoding a member of subfam-ily of protein-serine/threonine kinases,is amplified in humanovaria carcinomas[J].Proc Natl Acad Sci USA,1992,89:9267-9271.
  • 5Manning B D,Cantley L C.AKT/PKB signaling:navigation down-stream[J].Cell,2007,129:1261-1274.
  • 6Jetzt A,Howe J A,Horn M T,Maxwell E,Yin Z,Johnson D.Adeno-viral-mediated expression of a kinase-dead mutant of Akt in-duces apoptosis selectively in tumor cells and suppresses tumorgrowth in mice[J].Cancer Res,2003,63:6697-6706.
  • 7Bett A J,Haddara W,Prevec L,Graham F L.Homologous recombi-nation in packaging cell line[J].Proc Natl Acad Sci USA,1994,91:8802-8806.
  • 8He T C,Zhou S,da Costa L T,Yu J,Kinzler K W.pAdEasy System[J].Proc Natl Acad Sci USA,1998,95:2509-2514.
  • 9Anderson R D,Haskell R E,Xia H,Roessler B J,Davidson B L.RAPAd System[J].Gene Ther,2000,7:1034-1038.
  • 10Kim H J,Cui X,Hilsenbeck S G,Lee A V.Progesterone receptorloss correlates with human epidermal growth factor receptor overex-pression in estrogen receptor positive breast cancer[J].Clin CancerRes,2006,12:1013-1018.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部